Loxoprofen enhances intestinal barrier function via generation of its active metabolite by carbonyl reductase 1 in differentiated Caco-2 cells-Reference-Cited by-同舟云学术

Loxoprofen enhances intestinal barrier function via generation of its active metabolite by carbonyl reductase 1 in differentiated Caco-2 cells

Published:2021-10 Issue: Volume:348 Page:109634
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Endo Satoshi,Nishiyama Tsubasa,Matuoka Tomoe,Miura Takeshi,Nishinaka Toru,Matsunaga Toshiyuki,Ikari Akira

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference63 articles.

1. Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence;Carson;Drugs,1993

2. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic;Masferrer;Proc. Natl. Acad. Sci. U.S.A.,1994

3. Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy;Fujimori;Digestion,2010

4. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy, Aliment;Goldstein;Pharmacol. Ther.,2007

5. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy;Maiden;Gastroenterology,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the stereospecificity in the biotransformation of the four isomers of loxoprofen sodium in rats by chiral HPLC;Journal of Separation Science;2023-10-31

2. Simultaneous stereoisomeric separation of loxoprofen sodium and its alcohol metabolites. Application to a stereoselective pharmacokinetic study;Arabian Journal of Chemistry;2023-08

3. Synthesis and pharmacokinetic properties of novel cPLA2α inhibitors with 1-(carboxyalkylpyrrolyl)-3-aryloxypropan-2-one structure;Bioorganic & Medicinal Chemistry;2023-01

4. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression;Pharmaceutical Biology;2022-08-18